PerkinElmer Life Sciences

PPD, Inc.

3151 South 17th Street,
Wilmington,
North Carolina,
28412
United States of America
Tel: +910 251 0081
Fax: +910 762 5820

Print Email to a friend

PPD Discovery project leaders help sponsors develop and implement customized preclinical development plans that meet regulatory requirements in the countries where clinical trial applications are to be submitted. The proactive, integrated approach considers relevant drug development issues including the risk-benefit profile, the mechanism of action and predicted mechanism-based toxicity.

Further Information: http://www.ppddiscovery.com/



Related news from our archive

PPD Launches new Global Biostatistics Technology Infrastructure
The global information technology infrastructure increases company’s ability to deliver secure, timely clinical trial data.

PPD Enters into Strategic Collaboration with Merck
PPD acquires Merck’s vaccine testing lab and expands existing central lab service relationship.

PPD to Discover Biomarkers for PDL BioPharma
PPD's biomarker discovery sciences group will examine specified sample sets utilizing DeepLook™ analysis.